TIP Regimen Combined With Triplizumab Neoadjuvant Therapy for Locally Advanced Penile Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

May 31, 2024

Primary Completion Date

June 1, 2027

Study Completion Date

December 1, 2027

Conditions
Penile Cancer
Interventions
DRUG

Paclitaxel + Ifosfamide + Cisplatin & Toripalimab

Paclitaxel + Ifosfamide + Cisplatin \& Toripalimab

Trial Locations (1)

510060

RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors
lead

Sun Yat-sen University

OTHER